A Phase II Clinical Trial of Pembrolizumab Efficacy and Safety in Advanced Renal Medullary Carcinoma

SIMPLE SUMMARY: Renal medullary carcinoma (RMC) is an aggressive type of kidney cancer. Traditional treatments have limited effectiveness, so new strategies are needed. Studies of RMC tissues found signs of inflammation, suggesting that immune checkpoint therapies could be a potential treatment opti...

Descripción completa

Detalles Bibliográficos
Autores principales: Nze, Chijioke, Msaouel, Pavlos, Derbala, Mohamed H., Stephen, Bettzy, Abonofal, Abdulrahman, Meric-Bernstam, Funda, Tannir, Nizar M., Naing, Aung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417298/
https://www.ncbi.nlm.nih.gov/pubmed/37568622
http://dx.doi.org/10.3390/cancers15153806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417298/
https://www.ncbi.nlm.nih.gov/pubmed/37568622
http://dx.doi.org/10.3390/cancers15153806

Ejemplares similares